Enhance your lab operations and funding strategies with actionable advice on equipment leasing, financing, procurement, and life sciences industry trends.

Electra Therapeutics: First-in-class SIRP-targeted therapy for sHLH with ELA026—Excedr covers this major biotech funding round. Explore data and pipeline.
October 2025

NewLimit raises $45M to advance epigenetic reprogramming therapies targeting cellular aging—Excedr covers this major biotech funding round.
October 2025